SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001174947-24-000304
Filing Date
2024-03-08
Accepted
2024-03-07 21:45:19
Documents
6
Period of Report
2024-04-01

Document Format Files

Seq Description Document Type Size
1 PROXY STATEMENT ea0200572-02.htm DEF 14A 718193
2 GRAPHIC tallarity_logo.jpg GRAPHIC 60668
3 GRAPHIC tproxy_001.jpg GRAPHIC 1639113
4 GRAPHIC tproxy_002.jpg GRAPHIC 1306695
5 GRAPHIC tproxy_003.jpg GRAPHIC 1081154
6 GRAPHIC tproxy_004.jpg GRAPHIC 873382
  Complete submission text file 0001174947-24-000304.txt   7553217
Mailing Address 24 SCHOOL ST., 2ND FLOOR BOSTON MA 02108
Business Address 24 SCHOOL ST., 2ND FLOOR BOSTON MA 02108 401-426-4664
Allarity Therapeutics, Inc. (Filer) CIK: 0001860657 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-41160 | Film No.: 24732187
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)